المؤلفون: Yan S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 09; Vol. 15, pp. 1428101. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology, Humans ; Recurrence ; Treatment Outcome ; Transplantation Conditioning/methods ; Hematologic Neoplasms/therapy ; Hematologic Neoplasms/immunology

المؤلفون: Mao J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Ge J; Department of Oncology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Ding S; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Sun Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Nan F; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Yu H; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Ding J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Wang X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Liu Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. mingzhi_zhang1@163.com., Fu X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. zymfxr_2006@126.com.

المصدر: Scientific reports [Sci Rep] 2024 Sep 27; Vol. 14 (1), pp. 22356. Date of Electronic Publication: 2024 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Whole-Body Irradiation* , Cyclophosphamide*/therapeutic use, Humans ; Male ; Female ; Adult ; Adolescent ; Retrospective Studies ; Young Adult ; Transplantation, Homologous ; Child ; Transplantation Conditioning/methods ; Middle Aged ; Transplantation, Autologous ; Child, Preschool ; Graft vs Host Disease/etiology

المؤلفون: Milano A; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Lando G; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Di Maggio G; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Cornacchini G; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Grillo G; Hematology Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Cairoli R; Hematology Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Rossini S; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Crocchiolo R; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy. Electronic address: roberto.crocchiolo@ospedaleniguarda.it.

المصدر: Current research in translational medicine [Curr Res Transl Med] 2024 Sep; Vol. 72 (3), pp. 103464. Date of Electronic Publication: 2024 Aug 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier-Masson SAS Country of Publication: France NLM ID: 101681234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2452-3186 (Electronic) Linking ISSN: 24523186 NLM ISO Abbreviation: Curr Res Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: HLA Antigens*/immunology , Hematopoietic Stem Cell Transplantation*/mortality , Hematopoietic Stem Cell Transplantation*/adverse effects , Transplantation, Homologous*, Humans ; Male ; Female ; Adult ; Middle Aged ; Young Adult ; Isoantibodies/blood ; Isoantibodies/immunology ; Tissue Donors ; Histocompatibility Testing ; Aged ; Graft vs Host Disease/immunology ; Graft vs Host Disease/mortality ; Graft vs Host Disease/etiology ; Adolescent ; Retrospective Studies

المؤلفون: Cacciatore C; Unité de Médecine Interne (UF04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France, AP-HP, Hôpital St-Louis, F-75010 Paris, France; Université Paris Cité, IRSL, Recherche Clinique en hématologie, immunologie et transplantation, URP3518, F-75010 Paris, France., Baudet M; Department of Cardiology, Hospital Saint-Louis, Paris, France., Jean E; Département de Médecine Interne, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France; Centre de référence des syndromes drépanocytaires majeurs, thalassémies et autres pathologies rares du globule rouge et de l'érythropoïèse, Assistance Publique des hôpitaux de Marseille, 264, rue Saint-Pierre, 13005 Marseille, France., Presente S; Medical and Infectious Diseases ICU, APHP, Bichat Hospital, Paris, France., Para M; Department of Cardiovascular Surgery and Transplantation, Bichat Hospital, AP-HP, Paris, France; Laboratory of Vascular Translational Science, University of Paris-Cité, UMR 1148 Paris, France., Sonneville R; Department of Cardiovascular Surgery and Transplantation, Bichat Hospital, AP-HP, Paris, France; Laboratory of Vascular Translational Science, University of Paris-Cité, UMR 1148 Paris, France., Arangalage D; Cardiology Department, AP-HP, Bichat Hospital and Université de Paris-Cité, Paris, France., Ait Abdallah N; Service de Médecine Interne 2, maladies auto-immunes et systémiques, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Sicre de Fontbrune F; Hematology and Transplantation Department, Saint Louis Hospital, Paris, France., Prata PH; Hematology and Transplantation Department, Saint Louis Hospital, Paris, France., Crichi B; Unité de Médecine interne (UF07), AP-HP, Hôpital St-Louis, F-75010 Paris, France., Hervier B; Unité de Médecine interne (UF07), AP-HP, Hôpital St-Louis, F-75010 Paris, France., Parquet N; Unité d'Aphérèse Thérapeutique, Hôpital Saint-Louis, AP-HP, Paris, France., Soulat G; Radiologie, Hôpital Européen Georges Pompidou, APHP, INSERM 970, Université de Paris-Cité, France., Mousseaux E; Radiologie, Hôpital Européen Georges Pompidou, APHP, INSERM 970, Université de Paris-Cité, France., Burt RK; Scripps Health, La Jolla USA,; Genani Corporation, Chicago, USA., Farge D; Unité de Médecine Interne (UF04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France, AP-HP, Hôpital St-Louis, F-75010 Paris, France; Université Paris Cité, IRSL, Recherche Clinique en hématologie, immunologie et transplantation, URP3518, F-75010 Paris, France; Department of Medicine, McGill University, H3A 1A1, Montreal, Canada. Electronic address: dominique.farge-bancel@aphp.fr.

المصدر: Current research in translational medicine [Curr Res Transl Med] 2024 Sep; Vol. 72 (3), pp. 103449. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier-Masson SAS Country of Publication: France NLM ID: 101681234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2452-3186 (Electronic) Linking ISSN: 24523186 NLM ISO Abbreviation: Curr Res Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , COVID-19*/complications , COVID-19*/therapy , Extracorporeal Membrane Oxygenation*/methods , SARS-CoV-2*/immunology , Myocarditis*/therapy , Myocarditis*/etiology , COVID-19 Vaccines*/adverse effects , Transplantation, Autologous* , Scleroderma, Systemic*/therapy , Scleroderma, Systemic*/complications , Pericarditis*/therapy , Pericarditis*/etiology, Humans ; Female ; BNT162 Vaccine ; Middle Aged ; Vaccination/adverse effects ; Vaccination/methods ; Male

المؤلفون: Nagayama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.; Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Tochigi, Japan., Fujiwara SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.; Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Tochigi, Japan., Tominaga R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Yokoyama D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Noguchi A; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Furuki S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Oyama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Koyama S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Murahashi R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Nakashima H; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ikeda T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Hyodo K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Kawaguchi SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Toda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Umino K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Minakata D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Morita K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ashizawa M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Yamamoto C; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Sato K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ohmine K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1350-1356. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Transplantation, Homologous* , CD4-CD8 Ratio* , Hematologic Neoplasms*/therapy , Hematologic Neoplasms*/mortality , Hematologic Neoplasms*/diagnosis, Humans ; Male ; Adult ; Female ; Middle Aged ; Prognosis ; Young Adult ; Adolescent ; Retrospective Studies ; Aged ; Graft vs Host Disease/etiology ; Graft vs Host Disease/diagnosis ; Treatment Outcome ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism

المؤلفون: Makovich Z; University of South Florida Morsani College of Medicine, 560 Channelside Dr, Tampa, FL, 33602, USA. zmakovich@usf.edu., Radosavljevic I; University of South Florida Morsani College of Medicine, 560 Channelside Dr, Tampa, FL, 33602, USA., Chapyala S; University of South Florida Morsani College of Medicine, 560 Channelside Dr, Tampa, FL, 33602, USA., Handley G; H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Pena L; H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Mok S; H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Friedman M; H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.

المصدر: Digestive diseases and sciences [Dig Dis Sci] 2024 Sep; Vol. 69 (9), pp. 3488-3500. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Antiviral Agents*/therapeutic use , Drug Interactions*, Humans ; Hepatitis C/drug therapy ; Proline/analogs & derivatives ; Proline/therapeutic use ; Hepacivirus/drug effects ; Quinoxalines/therapeutic use

المؤلفون: Zhang J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Li X; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China., Liang R; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Duan S; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Yang X; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China., Hou Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Tian L; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China.

المصدر: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Aug 26; Vol. 15, pp. 1367241. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

مواضيع طبية MeSH: Cryopreservation* , Fertility Preservation*/methods , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Ovary*/pathology, Female ; Humans ; Young Adult ; Anemia, Aplastic/complications ; Anemia, Aplastic/therapy ; Graft Rejection/etiology ; Ovarian Reserve ; Transplantation, Homologous/adverse effects

المؤلفون: Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Li J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Liang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhang X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Chen S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Shi Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Hao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhao X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Gong M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhang F; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 16; Vol. 15, pp. 1425076. Date of Electronic Publication: 2024 Aug 16 (Print Publication: 2024).

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/therapy , Anemia, Aplastic*/mortality , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Recurrence*, Humans ; Male ; Female ; Adolescent ; Adult ; Child ; Young Adult ; Child, Preschool ; Middle Aged ; Treatment Outcome ; Antilymphocyte Serum/therapeutic use ; Antilymphocyte Serum/administration & dosage ; Transplantation, Homologous ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/administration & dosage ; Immunosuppression Therapy/methods ; Retrospective Studies ; Cyclosporine/therapeutic use ; Cyclosporine/administration & dosage

المؤلفون: Barbarito G; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Hiroshima L; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Oppizzi L; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Saini G; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Kristovich K; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Klein O; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Hosszu K; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Boehlke K; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Gupta A; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Mcavoy D; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Shyr D; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Boelens JJ; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Bertaina A; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California. Electronic address: aliceb1@stanford.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug; Vol. 30 (8), pp. 810.e1-810.e16. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/prevention & control , Antilymphocyte Serum*/therapeutic use , Antilymphocyte Serum*/administration & dosage , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects, Humans ; Child ; Male ; Female ; Adolescent ; Child, Preschool ; Acute Disease ; Infant ; Receptors, Antigen, T-Cell, alpha-beta/metabolism

المؤلفون: Ben Abdeljelil N; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ben Yaiche I; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ouerghi R; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Torjemane L; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Belloumi D; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Turki I; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Mekni S; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Kanoun RY; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ben Othman T; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ladeb S; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Aug; Vol. 17 (8), pp. 527-538. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/therapy , Anemia, Aplastic*/mortality , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Antilymphocyte Serum*/therapeutic use , Cyclophosphamide*/therapeutic use , Transplantation Conditioning*/methods , Vidarabine*/analogs & derivatives , Vidarabine*/therapeutic use , Vidarabine*/administration & dosage , Siblings*, Humans ; Male ; Female ; Animals ; Adolescent ; Retrospective Studies ; Adult ; Horses ; Rabbits ; Child ; Transplantation, Homologous ; Tissue Donors ; Young Adult ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Child, Preschool ; Middle Aged